Healthcare & Life Sciences
Galecto Biotech
France
activeseries-c-plus
series-c-plus
Stage
2010
Founded
2
Investors
About
Galecto Biotech develops treatments targeting fibrotic diseases and cancer by focusing on the modulation of galectin proteins to inhibit abnormal tissue scarring and tumor progression.
Explore Galecto Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.